Drivers of the immunopathogenesis in systemic lupus erythematosus. 2017

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). 2017

Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. 2017